Research has shown that mice with pancreatic cancer lived nearly three times longer when given CBD than those who were treated with chemotherapy alone. The study shows that CBD not only improves the side effects of chemotherapy, but also has anti-cancer properties.
It is already known that CBD is able to effectively alleviate symptoms such as nausea and vomiting, inflammation, anxiety, depression, psychosis and neurodegenerative disorders. What is less known is that CBD can help fight the tumour and cancer cells.
Pancreatic cancer is often only discovered at a late stage because it develops silently. Often there are already metastases and the prognosis is poor. The survival rate after one year for pancreatic cancer is 20% and the 5-year survival is only 2%. This makes pancreatic cancer one of the most deadly forms of cancer worldwide. That survival rate has hardly changed in recent decades and there are currently very few treatments available. Often the treatment focuses on limiting the symptoms caused by the cancer. CBD is therefore set to change all that.
Cannabidiol or CBD, which has no psychoactive effect, has long been known as a powerful remedy for cancer. This is due to its ability to interfere with cellular communication in tumours, as well as the ability to induce apoptosis (cell death by cancer). Some studies, including in vitro and animal studies conducted by San Francisco researchers at the California Pacific Medical Center, have also shown that CBD can influence the genes involved in aggressive metastases. CBD does this by helping to stop cell growth.